Overlap syndromeM35.10

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

PM-SCL Syndrome

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

  • Antibody-associated, clinically overlapping autoimmune diseases that meet the classification criteria of two or more clinically-phenomenologically defined autoimmune diseases or exhibit major symptoms of these diseases. The majority of these diseases are associated with characteristic autoantibodies against non-organ-specific nuclear or cytoplasmic autoantibodies whose formation is related to certain immunogenetic characteristics. Overlap syndromes are considered to exist when at least 2 of the following conditions are fulfilled: systemic lupus erythematosus (SLE); systemic scleroderma; idiopathic myositis (IM); Sjögren's syndrome (SS); rheumatoid arthritis (RA).
  • Serologically overlap syndromes characterized by distinct ANA patterns:
    • MCTD = mixed connective tissue disease, detection of U1-RNP antibodies.
    • PM-Scl syndrome = overlap syndrome with signs of PSS, dermatomyositis and chronic polyarthritis (rheumatoid arthritis); detection of PM-Scl antibodies.
    • Antisynthetase syndrome or Jo1 syndrome = overlap syndrome with myositis, fibrosing alveolitis, polyarthritis; less frequent association with sicca symptoms, Raynaud's phenomenon, PSS. In more than 80% of the cases detection of antibodies against aminoacyl-tRNA synthetases or Jo-1 antibodies.
    • Overlap syndrome with Ku antibodies = clinical picture with symptoms of systemic scleroderma, myositis and SLE.

LiteratureThis section has been translated automatically.

  1. Csepregi A et al (2003) Characterization of a lipoyl domain-independent B-cell autoepitope on the human branched-chain acyltransferase in primary biliary cirrhosis and overlap syndrome with autoimmune hepatitis. Clin Dev Immunol 10: 173-181
  2. Genth E (2000) Clinical manifestations, immunology and genetics of overlap syndromes. In: Plettenberg A, Meigel WN, Moll I (Hrsg) Dermatology at the threshold of the new millennium. Springer, Berlin Heidelberg New York, S. 57-59
  3. Lee MW et al (2003) Lupus erythematosus cells in the cutaneous lesion of overlap syndrome of dermatomyositis-SLE-like disease. At J Dermatopathol 25: 272-274
  4. Raijmakers R et al (2004) PM-Scl-75 is the main autoantigen in patients with the polymyositis/scleroderma overlap syndrome. Arthritis Rheum 50: 565-569
  5. Watanabe K et al (2003) Polyangitis overlap syndrome: a fatal case combined with adult Henoch-Schonlein purpura and polyarteritis nodosa. Catholic Int 53: 569-573

Authors

Last updated on: 29.10.2020